PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsHuman normal immunoglobulin
Human normal immunoglobulin
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
247 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Immunologic deficiency syndromesD007153—D84.912123117
Primary immunodeficiency diseasesD000081207——12123117
InfectionsD007239EFO_0000544—1241210
Communicable diseasesD003141——113128
Neoplasm metastasisD009362EFO_0009708—33—1—6
PolyneuropathiesD011115EFO_0009562A69.22——31—4
Chronic inflammatory demyelinating polyradiculoneuropathyD020277EFO_1000868G61.81——31—4
AgammaglobulinemiaD000361—D80.1—131—4
Graves ophthalmopathyD049970EFO_1001466——111—3
Eye diseasesD005128EFO_0003966H44—111—3
Show 11 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Covid-19D000086382—U07.1428—316
CarcinomaD002277—C80.0553——12
Breast neoplasmsD001943EFO_0003869C50632—112
SarcomaD012509——881——12
LymphomaD008223—C85.9371——10
SyndromeD013577——224—18
LeukemiaD007938—C95214——7
Precursor cell lymphoblastic leukemia-lymphomaD054198—C91.0113——5
HepatitisD006505—K75.9131——5
Hepatitis aD006506EFO_0007305B15131——5
Show 59 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NeoplasmsD009369—C8085——314
Non-small-cell lung carcinomaD002289——79———12
RecurrenceD012008——45——110
MelanomaD008545——65——19
Lung neoplasmsD008175—C34.9035——17
Colorectal neoplasmsD015179——23——16
Systemic sclerodermaD012595EFO_0000717M34—5——16
Diffuse sclerodermaD045743EFO_0000404——5——16
SclerosisD012598———5——16
Ovarian neoplasmsD010051EFO_0003893C5633——16
Show 104 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———9————9
Hiv infectionsD015658EFO_0000764B203————3
AnemiaD000740EFO_0004272D64.92————2
Kidney neoplasmsD007680EFO_0003865C641———12
Virus diseasesD014777—B342————2
HivD006678—O98.71———12
Castration-resistant prostatic neoplasmsD064129——1————1
Myeloproliferative disordersD009196—D47.11————1
Primary myelofibrosisD055728—D47.41————1
Myelomonocytic leukemia chronicD015477—C93.11————1
Show 42 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Autoimmune diseasesD001327EFO_0000540M30-M36————22
ArteritisD001167EFO_0009011I77.6————11
Pregnancy rateD018873——————11
Takayasu arteritisD013625EFO_1001857M31.4————11
Defense mechanismsD003674——————11
Treatment refusalD016312——————11
Aortic arch syndromesD001015——————11
Severe acute respiratory syndromeD045169EFO_0000694J12.81————11
Endometrioid carcinomaD018269——————11
Endometrial hyperplasiaD004714—N85.0————11
Show 19 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2,755 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use